Molecular Therapeutics Initiative

Today is #CalBigGive.

The Molecular Therapeutics Initiative at @ucberkeleyofficial.bsky.social accelerates drug discovery by connecting research with the tools and expertise needed to develop new therapies.

Help support the future of therapeutic innovation today at lnkd.in/gsGrsCJh

The future of biotech starts with exposure.

Through MTI lab tours, students see real discovery in action, from bench experiments to data analysis. Events like Bay Area Biotech Day help inspire tomorrow’s therapeutic innovators.

Support the pipeline through #CalBigGive at lnkd.in/gsGrsCJh

The next generation of drug discoverers is training now at @ucberkeleyofficial.bsky.social.

Hands-on biotech workshops. Strategic support for international female founders. New funding for Parkinson’s research.

Support future therapeutics through #CalBigGive:
givingday.berkeley.edu/giving-day/1...

Mayfield AI Garage at Berkeley Launch Event · Luma About Event AI-innovating UC Berkeley students - all majors, all degrees - are invited to this launch event for the Mayfield AI Garage at Berkeley. This…

Big news for AI builders! Mayfield AI Garage returns to @ucberkeleyofficial.bsky.social for a second year to support early-stage founders with funding, mentorship, compute resources, and incubator access. Students and recent alumni can apply now.

Kickoff event RSVP here: luma.com/MAIG2026

UC Berkeley Molecular Therapeutics Initiative Announces New Research Collaboration with BioMarin to Advance Therapies for Rare Genetic Diseases The UC Berkeley Molecular Therapeutics Initiative (MTI) announced a new collaboration agreement with BioMarin Pharmaceutical Inc. aimed at accelerating the discovery and development of innovative ther...

UC Berkeley MTI × BioMarin Pharmaceutical Inc. have formed a new alliance to translate campus discoveries into rare disease therapies and build a scalable, patient-focused innovation engine.

Learn more in our joint press release: moleculartherapeutics.org/mti-announce...

So excited to be leading this project combining transcriptional reprogramming and cutting-edge optical nanomaterials🧬 🧠

Grateful for the support from @mti-ucb.bsky.social Parkinson's Therapeutics Program as we work to shift the paradigm from dopamine replacement to circuit restoration.

Markita Landry & Stephan Lammel receive the 2026 MTI Parkinson’s Award!

Regenerative transcription factors + near-IR nanosensors enable real-time measurement of dopamine circuit repair.

Project led by Petra Mocellin (Lammel lab) and Shoichi Nishitani (Landry lab).

#Neuro #Parkinsons #MTIAwards

🚀 Apply by next Tuesday (02/17/2026) for up to $200K to build your Berkeley bio startup!

If you’ve been thinking about turning your science into impact... this is your sign. Don’t miss it. 🧬✨

@ucberkeleyofficial.bsky.social @berkeleyskydeck.bsky.social

⚡ Powering up mitophagy: MTI awardees Eunyong Park & Laurie Wang seek small molecules that boost PINK1, rescuing mitochondrial QC in Parkinson’s. $90k + full screening pipeline.
#Mitochondria #Parkinsons #MTIAwards @berkeleymcb.bsky.social
🔗 Read more at moleculartherapeutics.org/2026-mti-par...

🧬 Meet MTI awardees Ross Wilson & Hanqin Li!

They’re using CRISPR base editors to nudge α-syn levels down, aiming to prevent Lewy bodies before they form. Translational genetics in action.

#CRISPR #Parkinsons #MTIAwards

🔗 Read more at moleculartherapeutics.org/2026-mti-par...

@rosswilsonlab.org

@ucberkeleyofficial.bsky.social has opened campus nominations for the new UC Regents Innovation Awards, recognizing standout research, startups, and partnerships across the UC system.

⏰ Campus deadline: March 2, 2026 (noon)
🔗 regents.universityofcalifornia.edu/innovation-a...

#UCBerkeley

Congrats to MTI's Parkinson’s Therapeutics Awardees including MCB's Ross Wilson, Hanqin Li, Eunyong Park & Laurie Wang! 🎉👏 @rosswilsonlab.org

2026 MTI Parkinson’s Therapeutics Awardees Announced Parkinson’s disease afflicts more than ten million people worldwide, and with prevalence continuing to rise, the need for therapies that do more than merely mask symptoms has become urgent.

🧠 The MTI just named Ross Wilson & Hanqin Li, Markita Landry & Stephan Lammel, and Eunyong Park & Laurie Wang as our 2026 Parkinson’s Therapeutics Awardees. Each team gets $90k + discovery support. #Parkinsons #MTIAwards #Berkeley

💡 Read more at moleculartherapeutics.org/2026-mti-par...

Weill Neurohub Joins Forces with Genentech and Roche to Advance Neuroscience Research UCSF and UC Berkeley today announced a long-term research partnership with Genentech, a member of the Roche Group, and its parent company, Roche Holding AG, to speed the development of new therapeutic...

🚀 UCSF, UC Berkeley & UW faculty: the ATN Joint Projects are now accepting proposals. This Roche/Genentech‑supported opportunity funds two years of collaborative research to speed therapy development for brain & nervous system diseases. Learn more: www.ucsf.edu/news/2021/02...

🚀 Ready to build something big in biotech? @ucberkeleyofficial.bsky.social's LSEC Venture Grant Program gives life sciences founders up to $200K in support, plus access to @berkeleyskydeck.bsky.social startup resources. Apply by Feb 13, 2026! Full details & apply: lsec.berkeley.edu/venture-grant

Hands-on drug discovery at @ucberkeleyofficial.bsky.social! 🚀 Our Masters in Biotech workshop gave students practical lab experience in core drug discovery methods to bring real-world biotech skills into the classroom. Preparing the next generation of innovators! #BioTech #DrugDiscovery #Education

@ucberkeleyofficial.bsky.social’s life sciences ecosystem lit up #JPM2026 at the Berkeley Bio Startup Showcase, where biotech startups connected with investors and industry leaders. @mti-ucb.bsky.social is proud to have co-supported this event, hosted by the Life Sciences Entrepreneurship Center ✨

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy | NEJM One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from lef...

Data: www.nejm.org/doi/full/10....
Press release: ir.cytokinetics.com/press-releas...

One of our own has contributed to a newly approved medicine. The MTI at @ucberkeleyofficial.bsky.social congratulates the Cytokinetics team and our Executive Director, Dr. Julia Schaletzky, on FDA approval of aficamten for #HCM, available starting mid-January.
#BerkeleyHealth #GoBears #patientsfirst

Nobel wins, psychedelic lilies and a mission to Mars: UC Berkeley's top stories of 2025 - Berkeley News A look at some of the campus's biggest stories chronicled by UC Berkeley News.

@mti-ucb.bsky.social, we are thrilled that our Executive Director, Dr. Julia Schaletzky, is highlighted in @ucberkeleyofficial.bsky.social’s Top Stories of 2025 for her work advancing campus viewpoint diversity. Read here to learn more: news.berkeley.edu/2025/12/15/n...

UC has launched the Regents Innovation Awards, celebrating use-inspired research and entrepreneurship driving real-world impact. MTI shares this mission and our ED Julia Schaletzky serves on the Presidential Council supporting this work.
Learn more: regents.universityofcalifornia.edu/innovation-a...

Excited to co-sponsor the 2026 Gordon Research Conf. on Autophagy in Health & Disease! 🧬
Join us in Ventura, CA with top speakers incl. Eileen White, Ivan Đikić & Sharon A. Tooze.
🧫 Autophagy helps cells recycle their damaged components.
Apply here ➡️ www.grc.org/autophagy-in...
#GRC2026 #Autophagy

We’re thrilled to see this groundbreaking work from
@mti-ucb.bsky.social Faculty Co-director @dannomura.bsky.social! TRACERs represent a significant leap forward in targeting “undruggable” transcription factors with small molecules. We are honored to support this work!

#Epigenetics #DrugDiscovery

UC wins 5 Nobel Prizes in 3 days — and sets a new world record These discoveries span decades and disciplines, but they all have one important thing in common: They’ve all relied on competitive funding from the federal government.

The University of California just set a world record: 5 Nobel Prizes awarded to its faculty and alumni this year! 🏆🥇

A feat that underscores the impact of bold science and strong research ecosystems.

Read more here: www.universityofcalifornia.edu/news/uc-wins...

#NobelPrize #Research #Innovation

@mti-ucb.bsky.social is proud to have contributed to this exciting look at innovation at @ucberkeleyofficial.bsky.social.

Congrats to all involved on bringing "Startup Campus" to life!

#StartupCampus #BerkeleyInnovation #MTI

MTI Launches Parkinson’s Therapeutics Program, Invites Proposals BERKELEY — UC Berkeley’s Molecular Therapeutics Initiative (MTI) has launched a new funding program to accelerate drug discovery for Parkinson’s disease and related synucleinopathies.

UC Berkeley PIs & collaborators: MTI invites proposals for its newly launched Parkinson’s Therapeutics Program!

Offering up to 3 awards of $90k, and additional funded access to MTI's drug-hunting infrastructure.

🗓️ Deadline: Nov 16, 2025

More info 👇
moleculartherapeutics.org/mti-launches...

Assistant Professor -Molecular Therapeutics - Molecular and Cell Biology University of California, Berkeley is hiring. Apply now!

Excited about turning basic science into new therapeutic modalities? Want to work with brilliant and *friendly* colleagues? Hoping to be part of a public university that shapes California? Then come join us #MolecularTherapeutics, @ucberkeleyofficial.bsky.social !!!

aprecruit.berkeley.edu/JPF05098

Tenure track position alert! Assistant Professor of Molecular Therapeutics in MCB @UCBerkeley. Apply and come be our colleague! 🎉
aprecruit.berkeley.edu/JPF05098

Congratulations, Professor Yaghi! A remarkable achievement for our UC Berkeley community - Fiat Lux and Go Bears!

Congratulations, Professor Clarke! What an incredible moment for our UC Berkeley community - Fiat Lux and Go Bears!